Butyrophilin subfamily 3 member A1–Butyrophilin subfamily 2 member A1–phosphoantigen complex (BTN3A1–BTN2A1–phosphoantigen complex)

The butyrophilin subfamily 3 member A1–butyrophilin subfamily 2 member A1–phosphoantigen complex is a multi-protein membrane receptor assembly critical for the activation of Vγ9Vδ2 T cells, the dominant γδ T cell population in human peripheral blood. Upon detection of endogenous or microbial phosphoantigens (typically metabolic intermediates such as HMBPP or IPP produced by tumor cells or pathogens), the intracellular B30.2 domain of BTN3A1 binds these small molecules. This event triggers a conformational change and recruits BTN2A1, forming a receptor complex at the cell surface that is recognized by the Vγ9Vδ2 TCR and initiates γδ T cell activation. This pathway is essential for immune surveillance against malignancy and infection, with significant interest for immunotherapeutic exploitation. Structural studies have revealed the molecular mechanism: phosphoantigen functions as a “molecular glue” to promote stable BTN3A1–BTN2A1 association, with subsequent direct engagement of the Vγ9Vδ2 TCR, leading to potent immune cell activation and cytotoxicity against diseased cells.

Other names

BTN3A1–BTN2A1–pAg complexBTN3A1/BTN2A1/phosphoantigen sensing complexButyrophilin 3A1–Butyrophilin 2A1 complexCD277–BTN2A1–phosphoantigen complexBTN3A1–BTN2A1 complex (context-dependent; proper form explicitly includes "phosphoantigen")

Allosteric modulation of the BTN3A1–BTN2A1 complex by phosphoantigens (e.g., HMBPP, IPP) induces conformational changes that enable recognition and activation of Vγ9Vδ2 T cells. Potential agonistic or antagonistic antibody targeting of BTN3A1/BTN2A1 modulates γδ T cell response.